UBTECH ROBOTICS released its 2025 financial report on March 31, revealing that revenue surpassed 2 billion yuan for the first time, reaching 2.001 billion yuan, a significant year-on-year increase of 53.3%. The net loss attributable to shareholders narrowed by 37.4% compared to 2024, standing at 703 million yuan, while the gross profit margin jumped from 28.7% to 37.7%. Although this report card of "high growth and reduced losses" appears impressive, underlying profitability challenges, financial risks, and competitive pressures remain significant concerns.
The standout performance for UBTECH in 2025 was the explosive growth of its intelligent humanoid robot products and solutions business. Revenue from full-size embodied intelligent humanoid robots reached 820 million yuan, a dramatic increase of 22 times year-on-year, accounting for 41.1% of total revenue and becoming the primary revenue driver.
In terms of unit sales, the company delivered 1,079 units, an increase of over 358 times compared to the previous year, making it the only company globally to deliver more than a thousand full-size embodied intelligent humanoid robots annually. Based on these figures, the average selling price per full-size humanoid robot was approximately 760,000 yuan.
It is important to note that the humanoid robot industry is still in its early commercial stages, with a considerable distance remaining before reaching a tipping point for mass adoption. The industry consensus is that the per-unit cost of robots must fall below 150,000 yuan to achieve economic feasibility for large-scale replacement of human labor, given the average annual cost of a manufacturing worker is around 80,000 yuan. UBTECH's current selling price significantly exceeds this threshold.
Furthermore, despite the narrowed losses, the net loss attributable to shareholders of 703 million yuan remains substantial, indicating the company has not yet reached a profitability inflection point. In 2025, research and development expenses were 507 million yuan, and sales expenses were 471 million yuan. Combined, these two items accounted for nearly 50% of total revenue. The persistently high expense ratio consumed most of the gross profit. Although the humanoid robot business achieved a high gross margin of 54.6%, this margin is insufficient to cover the substantial R&D and market investment costs. Scale effects have not yet translated into profitability.
Simultaneously, concerns regarding asset quality in the company's financials require attention. As of the end of 2025, accounts receivable stood at 1.842 billion yuan, a 40% year-on-year increase, approaching the scale of the annual revenue. The provision for bad debts was 539 million yuan, representing a provision ratio of nearly 29%. This situation is primarily due to delayed payments from government-related clients. If collection conditions worsen, profits could be further eroded.
Additionally, the balance of construction in progress was 1.742 billion yuan, mainly allocated for the headquarters and industrial park construction. Once these assets are operational, increased depreciation expenses will follow. If capacity utilization does not align with revenue growth, this could persistently increase pressure on losses. Although the company's cash balance has grown in recent years, this growth largely stems from financing activities. Operating cash flow has not yet turned positive, indicating a lack of self-sustaining capability. Long-term reliance on external funding could further extend the path to profitability.
In summary, UBTECH's 2025 financial report demonstrates initial breakthroughs in the commercialization of humanoid robots. However, the high growth fails to conceal underlying profitability issues, with significant losses and asset quality concerns posing financial risks. The company's future ability to transition from "scale growth" to "profit growth" will depend on the pace of cost reduction, expense management capabilities, technological iteration efficiency, and the evolution of the competitive landscape. Given the industry's immaturity and the absence of a clear profitability turning point, potential risks include valuation corrections and performance falling short of expectations.
Comments